Cue Biopharma (CUE) Net Equity Issued and Repurchased (2018 - 2025)
Cue Biopharma (CUE) posted Net Equity Issued and Repurchased of $10.24 million for Q4 2025, compared with -$8,000 a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Net Equity Issued and Repurchased (2018 - 2025) Analysis & Trends
For FY2025, Cue Biopharma's Net Equity Issued and Repurchased came in at $28.29 million, up 161.6% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- In prior years, Cue Biopharma's Net Equity Issued and Repurchased was $10.81 million in FY2024 (-19.2%), $13.39 million in FY2023 (-41.0%), $22.7 million in FY2022 (+30.6%) and $17.38 million in FY2021 (-69.3%).
- Quarterly Net Equity Issued and Repurchased has run from a low of -$8,000 in Q4 2024 to a high of $18.05 million in Q2 2025 over five years.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2024, with growth of 764.4%; the weakest was Q1 2023, with a decline of 92.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Cue Biopharma | 121.14 Mn | 30.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 749,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 752,000.00 |
| Dec 31, 2024 | 57,000.00 |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 5.78 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Mar 31, 2022 | 5.49 Mn |
| Dec 31, 2021 | 7.03 Mn |
| Jun 30, 2021 | 309,000.00 |
| Mar 31, 2021 | 834,000.00 |
| Dec 31, 2020 | 56.93 Mn |
| Sep 30, 2020 | 14.33 Mn |
| Jun 30, 2020 | 1.04 Mn |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | 34.58 Mn |
| Sep 30, 2019 | 12.29 Mn |
| Jun 30, 2019 | 3.75 Mn |
API Access
Cue Biopharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();